Accelmed

Accelmed Partners specializes in private equity investments targeting the lower middle-market HealthTech sector in the United States. With more than ten years of industry experience, the firm brings together deep operational knowledge, financial acumen, and extensive healthcare networks to support management teams across various healthcare technology segments. Their investment strategy focuses on commercial-stage companies that demonstrate significant potential for expansion and value creation in medical devices, diagnostic tools, digital health platforms, and technology-enabled healthcare services.

The firm's investment philosophy centers on partnering with companies that share their core values of integrity, transparency, and tenacity. Accelmed seeks out businesses that leverage innovative technologies to address critical healthcare challenges, including improving patient outcomes, reducing systemic costs, and enhancing operational efficiency throughout the healthcare ecosystem. This targeted approach allows them to identify promising companies with proven business models that are positioned to scale and transform their respective market segments.

Currently managing over $630 million in equity capital, Accelmed Partners maintains an active investment strategy through their second private equity fund, Accelmed Partners II. The firm typically targets companies with established revenue streams and market validation, providing not just capital but also strategic guidance, industry connections, and operational support to accelerate growth trajectories. Their hands-on investment approach includes assistance with market expansion, product development, regulatory navigation, and strategic acquisitions to build comprehensive healthcare technology platforms.

Accelmed's portfolio reflects their commitment to advancing healthcare technology across multiple dimensions of the industry. Their investment team combines backgrounds in healthcare operations, clinical practice, technology development, and financial markets to provide portfolio companies with multifaceted support. This comprehensive expertise enables Accelmed to identify emerging trends in healthcare delivery, regulatory developments, and technological innovations that shape their investment decisions and portfolio company strategies. The firm maintains offices in New York and Israel, leveraging a global perspective on healthcare innovation while focusing their investments on the U.S. market.